Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    MK-869, L-754030, Emend, Aprepitant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,167Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Alivus Life Sciences
    India
    		 Daewoong Bio Co., Ltd. Su6580-19-ND(1) aprepitant 2017-12-08 Glenmark Life Sciences Limited India Plot No. 3109, GIDC, Industrial Estate, Ankleshwar, City : Ankleshwar - 393 002, Dist. Bharuch, Gujarat State, India
    29/11/2025 Alivus Life Sciences
    India
    		 Aging Life Science Co., Ltd. Su6580-19-ND(2) aprepitant 2018-11-09 Glenmark Life Sciences Limited India Plot No. 3109, GIDC, Industrial Estate, Ankleshwar, City : Ankleshwar - 393 002, Dist. Bharuch, Gujarat State, India